BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5549492)

  • 1. Hydroxyprogesterone caproate therapy in advanced endometrial cancer.
    Reifenstein EC
    Cancer; 1971 Mar; 27(3):485-502. PubMed ID: 5549492
    [No Abstract]   [Full Text] [Related]  

  • 2. The treatment of advanced endometrial cancer with hydroxyprogesterone caproate.
    Reifenstein EC
    Gynecol Oncol; 1974 Aug; 2(2-3):377-414. PubMed ID: 4616884
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of 19-nor-17 alpha-hydroxyprogesterone caproate in endometrial cancer].
    Márquez J; Dabancens A; González O; Rosmanich A
    Rev Chil Obstet Ginecol; 1976; 41(5):304-11. PubMed ID: 1030512
    [No Abstract]   [Full Text] [Related]  

  • 4. Progesterone caproate in the treatment of endometrial cancer.
    Sherman AI
    Obstet Gynecol; 1966 Sep; 28(3):309-14. PubMed ID: 4162030
    [No Abstract]   [Full Text] [Related]  

  • 5. 17-alpha-hydroxyprogesterone caproate treatment of gynecologic cancer.
    Hreshchyshyn MM; Graham RM
    Am J Obstet Gynecol; 1969 Jul; 104(6):916-8. PubMed ID: 5792777
    [No Abstract]   [Full Text] [Related]  

  • 6. Progestogens in the treatment of carcinoma of the endometrium.
    Kennedy BJ
    Surg Gynecol Obstet; 1968 Jul; 127(1):103-14. PubMed ID: 5657772
    [No Abstract]   [Full Text] [Related]  

  • 7. Endometrial carcinoma in Stein-Leventhal syndrome treated with hydroxyprogesterone caproate.
    Eddy WA
    Am J Obstet Gynecol; 1978 Jul; 131(5):581-2. PubMed ID: 677198
    [No Abstract]   [Full Text] [Related]  

  • 8. Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy?
    Bokhman JV; Chepick OF; Volkova AT; Vishnevsky AS
    Gynecol Oncol; 1985 Feb; 20(2):139-55. PubMed ID: 3972284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic observations on the effect of 17-alpha-hydroxyprogesterone-17-n-caproate on endometrial carcinoma.
    Varga A; Henriksen E
    Obstet Gynecol; 1965 Nov; 26(5):656-64. PubMed ID: 5855353
    [No Abstract]   [Full Text] [Related]  

  • 10. [Excretion of follicle-stimulating and steroid hormones in patients with uterine cancer during treatment with 17-hydroxyprogesterone caproate].
    Sharoukhova KS; Vershinina GN; Murav'eva NI; Smirnova KD; Goncharova MG
    Akush Ginekol (Mosk); 1970 Oct; 46(10):9-13. PubMed ID: 5519750
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of adjuvant hormonotherapy on the results of the radiation treatment of patients with cancer of the corpus uteri].
    Bokhman IaV; Stoliarova IV; Gastev AIu
    Vopr Onkol; 1987; 33(4):49-52. PubMed ID: 3296435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EFFECT OF 17-ALPHA-HYDROXYPROGESTERONE 17-N-CAPROATE ON VARIOUS PELVIC MALIGNANCIES.
    VARGA A; HENRIKSEN E
    Obstet Gynecol; 1964 Jan; 23():51-62. PubMed ID: 14110061
    [No Abstract]   [Full Text] [Related]  

  • 13. Megestrol acetate in the management of advanced endometrial carcinoma.
    Wait RB
    Obstet Gynecol; 1973 Jan; 41(1):129-36. PubMed ID: 4682608
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvant hydroxyprogesterone caproate in stage I endometrial carcinoma: changes in numbers and reactivities of some blood lymphocyte subpopulations.
    Onsrud M
    Gynecol Oncol; 1982 Dec; 14(3):355-64. PubMed ID: 6983994
    [No Abstract]   [Full Text] [Related]  

  • 15. [Synthetic progestins in combined treatment of cancer of the uterine body].
    Iatskovskai NL
    Vopr Onkol; 1976; 22(3):25-8. PubMed ID: 936523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term progestogen treatment of endometrial carcinoma. Histological, histochemical and hormonal studies.
    Moe N
    Acta Obstet Gynecol Scand; 1972; 51(1):55-62. PubMed ID: 4261828
    [No Abstract]   [Full Text] [Related]  

  • 17. [Progestins in combined treatment of endometrial cancer].
    Voznyĭ EK; Titova VA
    Sov Med; 1990; (9):102-7. PubMed ID: 2148437
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjuvant hormone therapy of primary endometrial carcinoma with oxyprogesterone caproate.
    Bokhman JV; Chepick OF; Volkova AT; Vishnevsky AS
    Gynecol Oncol; 1981 Jun; 11(3):371-8. PubMed ID: 6788657
    [No Abstract]   [Full Text] [Related]  

  • 19. Progestogen treatment of recurrent endometrial carcinoma.
    Malkasian GD; Decker DG; Mussey E; Johnson CE
    Am J Obstet Gynecol; 1971 May; 110(1):15-23. PubMed ID: 5573604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinico-morphological changes during treatment of endometrial cancer with progestins].
    Shuvaeva NI; Vekhova LI; Nikitina NI; Gosh TE; Nevskaia EA
    Vopr Onkol; 1980; 26(6):22-7. PubMed ID: 7385724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.